Protective Effects of Vitamin C and L-Carnitine on Moxifloxacin-Induced Nephrotoxicity in Rats
DOI:
https://doi.org/10.31185/wjps.928Keywords:
Moxifloxacin, Nephrotoxicity, Oxidative Stress, Vitamin C, L-CarnitineAbstract
Moxifloxacin is an essential clinically relevant fluoroquinolone antibiotic that is employed against a great variety of bacterial infections. Nevertheless, its use in clinical practice is linked to nephrotoxicity that is a severe adverse outcome that involves oxidative stress pathways. This paper sought to compare the ameliorative property of two strong antioxidants, Vitamin C and L-Carnitine, to moxifloxacin induced renal injury on a male albino rat model. The rat population was randomly divided into four groups of ten (i.e. a control group, a group treated with moxifloxacin (80 mg/kg), a group treated with moxifloxacin and Vitamin C (500 mg/kg) and a group treated with moxifloxacin and L-Carnitine (600 mg/kg). All therapies were taken in the form of gavage every day and in 30 days. To evaluate the renal damage, the serum urea and creatinine levels were measured, and kidney tissues were examined histopathologically to observe structural changes in tissues. The findings revealed that the serum levels of urea and creatinine were highly increased in moxifloxacin treated rats in isolation of the control group and signified poor kidney functioning. Histopathological analysis showed severe renal injury, such as shrinkage of the glomeruli, tubular necrosis, inflammation of the tissue by cells and cytoarchitectural degeneration. Inflammation and cellular injury were measured using systematic histopathological scoring of tissue sections to measure glomerular integrity, extent tubular necrosis, intensity of inflammatory infiltration and general structural preservation. On the other hand, the serum urea and creatinine levels and the histopathological injury scores in groups co-treated with Vitamin C or L-Carnitine were significantly lower and the levels were much lower as well. The glomerular and tubular organization of the kidney tissues of antioxidant-treated groups was better and the inflammation and cellular damage were significantly lower. This paper proves that moxifloxacin causes acute nephrotoxicity, and the process occurs via oxidative stress. Vitamin C or L-Carnitine co-administration has a significant effect in curing renal biochemical dysfunction and histopathological damage. The results indicate the possibility of the clinical use of antioxidant supplementation as a preventive measure against nephropathy induced by moxifloxacin.
References
[1] V. T. Andriole, "The quinolones: Past, present, and future," Clinical Infectious Diseases, vol. 41, no. Suppl. 2, pp. S113–S119, 2005.
[2] D. Schnell et al., "Moxifloxacin in patients with renal impairment: a pharmacokinetic and safety evaluation," Clinical Infectious Diseases, vol. 50, no. 4, pp. e27-e35, 2010.
[3] L. Huang, Y. Li, and C. Zhang, "Mechanisms of drug-induced renal fibrosis," Frontiers in Pharmacology, vol. 11, p. 177, 2020.
[4] A. M. El-Bakry, H. El-Said, and W. El-Kholy, "Paracetamol induced nephrotoxicity and oxidative stress in rats: The protective role of Nigella sativa," Pharmaceutical Biology, vol. 54, no. 10, pp. 2082-2091, 2016.
[5] Y. Zhao, "Mechanisms of drug-induced nephrotoxicity associated with oxidative stress and mitochondrial dysfunction," Scientific Reports, vol. 15, Art. no. 49996, 2025.
[6] J. M. Dennis and P. K. Witting, "Protective role for antioxidants in acute kidney disease," Nutrients, vol. 9, no. 7, p. 718, 2017.
[7] M. Akbaribazm et al., "Anti-inflammatory, anti-oxidative and anti-apoptotic effects of Heracleum persicum L. extract on rats with gentamicin induced nephrotoxicity," Asian Pacific Journal of Tropical Biomedicine, vol. 11, no. 2, pp. 47-58, 2021.
[8] A. Bedir et al., "The role of oxidative stress in drug-induced nephrotoxicity," Journal of Clinical Nephrology, vol. 5, no. 2, pp. 45-52, 2021.
[9] H. Kara et al., "Moxifloxacin induced nephrotoxicity in rats and the protective role of N-acetylcysteine," Renal Failure, vol. 37, no. 5, pp. 875-881, 2015.
[10] M. A. Perazella, "Drug-induced acute interstitial nephritis: a 21st-century perspective," Clinical Journal of the American Society of Nephrology, vol. 14, no. 7, pp. 1109-1111, 2019.
[11] R. E. Mostafa, N. M. Shaffie, and R. M. Allam, "Protective effects of royal jelly and Echinacea against moxifloxacin-induced renal and hepatic injury in rats," Drug and Chemical Toxicology, vol. 46, no. 6, pp. 1193–1202, 2023.
[12] A. A. El-Nekeety et al., "Protective effect of Aquilegia vulgaris (L.) against lead acetate-induced oxidative stress and nephrotoxicity in albino rats," Ecotoxicology and Environmental Safety, vol. 97, pp. 28-37, 2014.
[13] M. M. Sayed-Ahmed et al., "Cisplatin-induced nephrotoxicity: role of superoxide and the protective effect of antioxidant vitamins C and E," Food and Chemical Toxicology, vol. 46, no. 10, pp. 3293-3297, 2008.
[14] M. M. Sayed-Ahmed et al., "Propionyl-L-carnitine as a protector against doxorubicin-induced cardiotoxicity in rats," Pharmacological Research, vol. 49, no. 4, pp. 335-341, 2004.
[15] M. G. Scioli et al., "L-carnitine and its derivatives in the treatment of ischemia-reperfusion injury: a review of the literature," Current Pharmaceutical Design, vol. 20, no. 38, pp. 6028-6034, 2014.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Asmaa Al-Obaidi, Ali Ali Fayadh Bargooth
This work is licensed under a Creative Commons Attribution 4.0 International License.
